In July 2019, a jury awarded $229.6 million in the largest medical malpractice verdict ever in the United States.
Successfully navigating the professional liability environment in ob/gyn can be difficult, especially amid a global pandemic. Liability issues and malpractice claims continue to increase, which may call for a shift in the ways of ob/gyn practice.
In July 2019, a jury awarded $229.6 million in the largest medical malpractice verdict ever in the United States1. In that case, her provider said she could terminate the pregnancy because the baby was non-viable. As a result, the patient declined a C-section and her provider stopped monitoring the fetus. With insufficient levels of oxygen to the brain, the baby was born with brain damage2.
Four months later, another jury award of $229.6 million was settled3. According to local news sources, the infant suffered brain damage after an emergency C-section was not performed3.
As Vice President of Risk Management, Quality, and Compliance for the nation’s largest ob/gyn hospitalist organization, Heather Moore discusses the issues surrounding medical malpractice claims and identifies key risk mitigation strategies in a recent article from Medical Economics.
Moore advises ob/gyns and hospital systems to be proactive, saying that hospitals should take steps to address risk mitigation and quality control. Doing so can significantly decrease the likelihood of a successful medical malpractice claim.
Moore also discusses a 2016 study by Ob Hospitalist Group that aimed to identify key risk mitigation strategies that resulted in significant claims reductions. They found that a 31% reduction in perinatal serious-harm events at hospitals was associated with one factor: the implementation of an OB hospitalist program.
Gain additional insight and expertise into medical malpractice claims and risk reduction in Moore’s article for Medical Economics,‘The evolving liability landscape and obstetrical care.’
__
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
Impact of antiepileptic medications and sex hormones on maternal and child outcomes in epilepsy
May 16th 2024Paula Emanuela Voinescu, MD, PhD, director of the Women's Epilepsy Program at Brigham and Women's Hospital, talked about the influence of sex hormones on maternal outcomes in pregnant women with epilepsy treated with antiseizure medication.
Read More
Prenatal cannabis and nicotine use linked to adverse pregnancy outcomes
May 14th 2024A recent study highlights the heightened risks of maternal and neonatal morbidity and mortality associated with combined cannabis and nicotine use during pregnancy, urging further investigation into their impact on short- and long-term outcomes.
Read More
Echogenic Mass identified as key predictor for retained products of conception
May 13th 2024Discover how recent findings highlight the significance of echogenic masses in accurately diagnosing post-pregnancy complications, shedding light on effective management strategies and reducing the need for invasive interventions.
Read More